Subscribe To
Novartis expects fy22 sales, profit growth; sandoz review continues
Novartis AG NVS reported a Q4 net income of $16.31 billion, up from $2.1 billion the previous year, benefiting from the sale of its stake in Roche...
February 2, 2022, 6:42 am
Johnson & johnson hunting for biotech, medical device acquisitions
Johnson & Johnson ( JNJ , Financial) is on the lookout for medical device and biotech companies to add to the fold, but in the case of the latter, it ...
January 27, 2022, 4:57 pm
Johnson & johnson hunting for biotech, medical device acquisitions
Johnson & Johnson ( JNJ , Financial) is on the lookout for medical device and biotech companies to add to the fold, but in the case of the latter, it ...
January 27, 2022, 4:57 pm
Johnson & johnson hunting for biotech, medical device acquisitions
Johnson & Johnson ( JNJ , Financial) is on the lookout for medical device and biotech companies to add to the fold, but in the case of the latter, it ...
January 27, 2022, 4:57 pm
Pfe vs. rhhby: which stock should value investors buy now?
PFE vs. rhhby: Which Stock Is the Better Value Option?...
January 4, 2022, 1:05 pm
Pfe vs. rhhby: which stock should value investors buy now?
PFE vs. rhhby: Which Stock Is the Better Value Option?...
January 4, 2022, 1:05 pm
Pfe vs. rhhby: which stock should value investors buy now?
PFE vs. rhhby: Which Stock Is the Better Value Option?...
January 4, 2022, 1:05 pm
Genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: rhh...
October 8, 2021, 4:48 pm
Genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: rhh...
October 8, 2021, 4:48 pm
Genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: rhh...
October 8, 2021, 4:48 pm
Roche's alzheimer's candidate secures fda breakthrough designation
Roche Holdings AG's (OTC: rhhby) gantenerumab antibody received breakthrough therapy designation from...
October 8, 2021, 3:37 pm
Roche's alzheimer's candidate secures fda breakthrough designation
Roche Holdings AG's (OTC: rhhby) gantenerumab antibody received breakthrough therapy designation from...
October 8, 2021, 3:37 pm
Roche's alzheimer's candidate secures fda breakthrough designation
Roche Holdings AG's (OTC: rhhby) gantenerumab antibody received breakthrough therapy designation from...
October 8, 2021, 3:37 pm
Ad hoc announcement pursuant to art. 53 lr: genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: rhh...
October 8, 2021, 11:40 am
Ad hoc announcement pursuant to art. 53 lr: genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: rhh...
October 8, 2021, 11:40 am
Ad hoc announcement pursuant to art. 53 lr: genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: rhh...
October 8, 2021, 11:40 am
Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: rhh...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: rhhby) today announced that new OCREVUS® (ocrelizu...
October 5, 2021, 1:00 am
Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: rhh...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: rhhby) today announced that new OCREVUS® (ocrelizu...
October 5, 2021, 1:00 am